WebMay 8, 2015 · In 2005, an anti-HIV drug he helped develop, FTC, netted $540 million for Emory—which gave $71 million to Schinazi. Emory and Schinazi have made millions more in royalty fees for a sister drug, 3TC, which treats both HIV and hepatitis B. And Schinazi, who also runs a lab at Atlanta's VA Medical Center, had a hand in two other drugs on the market. Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, chikungunya, and other emerging viruses. These treatment options include antiviral agents as well as synthetic, biochemical, pharmacological and molecular genetic approaches, in…
King of the pills Science
WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over 12,663,684$ and over the last 7 years Raymond sold DTIL stock worth over 1,696,250 WebPharmasset science founder lands a fortune from $11B Gilead buyout Fierce Biotech. Fierce Pharma. Fierce Biotech. Fierce Healthcare. Fierce Life Sciences Events. Research. … does hornfels react to acid
Who Got Really Rich This Week? Elon Musk, a College Professor, A …
WebRaymond F. Schinazi’s income source is mostly from being a successful . He is from Egypt. We have estimated Raymond F. Schinazi's net worth , money, salary, income, and assets. Net Worth in 2024. $1 Million - $5 Million. Salary in 2024. Under Review. WebRaymond F. Schinazi’s income source is mostly from being a successful . He is from Egypt. We have estimated Raymond F. Schinazi's net worth , money, salary, income, and assets. … WebThe estimated net worth of Raymond F. Schinazi is at least $14.20 million as of May 4th, 2024. Mr. Schinazi owns 7,674,960 shares of Cocrystal Pharma stock worth more than … faber e-tec gmbh